Why earlier treatment changes the review question
A first-visit guide asks: what is this diagnosis, and what should happen next? A review after earlier treatment asks a different question: what was given, how did the disease respond, and what options remain? The exact lymphoma type matters because Hodgkin and non-Hodgkin lymphoma are not treated the same way. Even within Hodgkin lymphoma, the review depends on stage, symptoms, pathology subtype and how the disease responded to the first treatment.
For an overseas patient, the practical task is not to repeat the diagnostic journey. It is to show the treating team a clear timeline: when the diagnosis was confirmed, what treatment was given, what scans were done before, during and after that treatment, and what the current concern is. Without that sequence, a specialist cannot judge whether the earlier treatment was completed as planned, whether the response was adequate, or whether a different approach is now being considered.
This is why a records-based review is not the same as a first consultation. The clinician is not starting from zero. They are assessing an existing treatment history and asking what the next decision should be. That decision may be observation, further treatment, a clinical trial assessment, or a different specialist referral. The review does not confirm eligibility for any specific therapy, trial or transplant.
What to include about pathology and response scans
The pathology report is the foundation. Ask the treating hospital for the original biopsy report, including the subtype and any immunohistochemistry or molecular studies. If the biopsy was done elsewhere, a pathology re-review may be requested by the receiving team. This is not a routine formality; it confirms the diagnosis on which all later treatment decisions depend. The receiving clinician decides whether re-review is needed.
Response scans are the second essential record. These may include baseline imaging before treatment, interim scans during treatment, and end-of-treatment scans. The reports should state the date, the body areas imaged, the findings and the conclusion. If the images themselves are available on disc or through a secure link, ask whether the receiving hospital wants the actual images or only the reports. Do not assume that a written report is enough for every review.
Blood tests, bone marrow reports, heart and lung function tests, and any fertility or infection screening done before treatment may also be relevant. The goal is not to send every page ever produced. It is to send the records that explain the diagnosis, the treatment given and the response. A short cover summary listing the documents in order helps the clinician find the key information quickly.
How to describe earlier treatment without rewriting the whole history
Write a one-page treatment summary in plain language. Include the date of diagnosis, the subtype if known, the stage if known, the names of the treatment drugs or regimens, the number of cycles completed, the dates of treatment, and any treatment that was stopped, delayed or changed. If radiotherapy was given, include the area treated and the dates. If the patient is currently on treatment, state that clearly and include the most recent cycle date.
Do not try to interpret the treatment yourself. The specialist needs the original treatment records, not a patient's summary of whether it worked. If the earlier treatment was given in another country, include the original prescription or treatment sheet if available. If the records are in another language, ask the hospital whether a certified translation is needed. The receiving team decides what it can accept.
The most useful question to answer in the summary is: what is the current clinical situation? Is the patient in follow-up after completed treatment, currently receiving treatment, or considering a new option because of a scan result or symptom? That single sentence tells the specialist why the review is being requested and what decision is pending.
Specialist sequencing: what the China team needs to confirm
Hodgkin lymphoma care often involves more than one specialty. Medical oncology, radiation oncology, pathology and sometimes transplant or cellular therapy teams may need to review the case. The order in which these reviews happen matters. A pathology re-review may need to come before a treatment opinion. A response assessment may need to come before a discussion about further therapy. Ask the coordinating team how the reviews will be sequenced and what information each specialist needs.
Do not assume that a single appointment will answer every question. The receiving hospital decides which specialists are appropriate and whether a multidisciplinary review is needed. If the case is complex, the hospital may ask for additional records or repeat tests before giving an opinion. That is a clinical decision, not a scheduling preference.
For an overseas patient, the practical question is whether the review can be done remotely first, or whether travel is needed before a clinical decision can be made. This depends on the hospital's requirements and the completeness of the records. Ask the named provider what it needs before it can give a written opinion, and what remains undecided until an in-person assessment.
Questions to ask before you send records or travel
A useful review starts with clear questions. Ask the treating team: does it need the original pathology slides or blocks, or are reports sufficient? Does it need the actual scan images, or are reports enough? Does it require a pathology re-review before giving an opinion? Does it need a current blood test or scan before the review? What language must the records be in? These are administrative and clinical questions that the hospital must answer for its own process.
Also ask what the review can and cannot confirm. A records-based opinion can assess the earlier treatment and response, but it does not establish eligibility for a clinical trial, transplant or a specific therapy. Those decisions require the treating hospital's own assessment, and sometimes an in-person evaluation. If a trial or transplant is being considered, ask separately what the eligibility process involves and what records are required.
Finally, ask what the next step is after the review. Will the hospital provide a written opinion, recommend a specific appointment, or ask for more records? Knowing this in advance helps you decide whether to travel and what to prepare. An initial enquiry is free and can start with a brief summary; you do not need to buy a proxy consultation before asking whether the case is suitable for review.
Practical preparation and the limits of a remote review
Prepare a single folder or secure digital file with the pathology report, treatment summary, response scan reports, and the most recent clinic note. Label each document with its date and type. If the patient is currently on treatment, include the most recent treatment record and any current symptoms. Do not stop or change treatment to prepare for an overseas review. Urgent or worsening symptoms need local medical care first.
A remote review has limits. It cannot replace a physical examination, and it may not be able to confirm the current disease status without a recent scan or test. The receiving clinician will say what is missing and what must be confirmed in person. If the review suggests a next step, that step still depends on the hospital's acceptance and the treating team's assessment.
The goal of presenting earlier treatment clearly is to give the specialist a accurate starting point. It does not guarantee a particular outcome, access to a specific therapy, or acceptance for treatment in China. It simply makes the clinical question answerable. If you are unsure what to send first, start with a brief summary of the diagnosis, the treatment given and the current question. The coordinating team can then explain what records the hospital needs next.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.